PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $148,000 | -78.5% | 17,582 | -77.7% | 0.01% | -47.1% |
| Q4 2019 | $689,000 | +282.8% | 78,688 | +454.1% | 0.02% | +183.3% |
| Q2 2019 | $180,000 | -53.6% | 14,200 | +42.0% | 0.01% | -53.8% |
| Q1 2019 | $388,000 | -53.1% | 10,000 | -75.4% | 0.01% | -59.4% |
| Q4 2018 | $827,000 | +240.3% | 40,654 | +667.1% | 0.03% | +190.9% |
| Q3 2018 | $243,000 | +17.4% | 5,300 | +51.4% | 0.01% | 0.0% |
| Q2 2018 | $207,000 | -89.4% | 3,500 | -78.6% | 0.01% | -93.9% |
| Q3 2017 | $1,960,000 | +580.6% | 16,365 | +395.9% | 0.18% | +496.7% |
| Q2 2017 | $288,000 | -76.9% | 3,300 | -82.3% | 0.03% | -85.8% |
| Q3 2016 | $1,247,000 | – | 18,596 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |